Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Castelo

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
ESMO Open|June 1, 2022
COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE)L Castelo-Branco, Z Tsourti, S Gennatas, et al.
The British Journal of Dermatology|July 24, 2018
Evaluation of the reliability and validity of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) in paediatric cutaneous lupus among paediatric dermatologists and rheumatologistsC J Kushner, M Tarazi, R G Gaffney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2025
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitorsE S M van Aken, B Devnani, A Prelaj, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2023
Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic reviewA Prelaj, V Miskovic, M Zanitti, et al.
ESMO Open|February 27, 2026
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with EGFR, ALK, or BRAF/MEK inhibitorsE S M van Aken, S M O'Cathail, A K Gandhi, et al.
Journal of the American Academy of Dermatology|April 29, 2022
Cross-sectional characteristics of pediatric-onset discoid lupus erythematosus: Results of a multicenter, retrospective cohort studyN Ezeh, K Ardalan, K A Buhr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2026
ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumoursK S Saini, M Koopman, D Martins-Branco, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
ESMO Open|June 1, 2022
COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE)L Castelo-Branco, Z Tsourti, S Gennatas, et al.
The British Journal of Dermatology|July 24, 2018
Evaluation of the reliability and validity of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) in paediatric cutaneous lupus among paediatric dermatologists and rheumatologistsC J Kushner, M Tarazi, R G Gaffney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2025
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitorsE S M van Aken, B Devnani, A Prelaj, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2023
Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic reviewA Prelaj, V Miskovic, M Zanitti, et al.
ESMO Open|February 27, 2026
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with EGFR, ALK, or BRAF/MEK inhibitorsE S M van Aken, S M O'Cathail, A K Gandhi, et al.
Journal of the American Academy of Dermatology|April 29, 2022
Cross-sectional characteristics of pediatric-onset discoid lupus erythematosus: Results of a multicenter, retrospective cohort studyN Ezeh, K Ardalan, K A Buhr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2026
ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumoursK S Saini, M Koopman, D Martins-Branco, et al.
Pageof 6